Jun Chen

Jun Chen

Auto-generated profile, based on publicly available information

Jun Chen

Advanced Imaging Research Center The University of Texas Southwestern Medical Center Dallas Texas USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2021 in Radiology
Verified
Journal Article
Closed access
JPJae Mo Park
Jae Mo Park
CHCrystal E. Harrison
Crystal E. Harrison
JMJunjie Ma
Junjie Ma
JCJun Chen
Jun Chen
JRJames Ratnakar
James Ratnakar
CMCraig R. Malloy
Craig R. Malloy
This study demonstrates the feasibility of imaging skeletal muscle metabolism using hyperpolarized carbon 13 pyruvate MRI and the sensitivity of in vivo pyruvate metabolism to exercise states. Background Pyruvate dehydrogenase (PDH) and lactate dehydrogenase are essential for adenosine triphosphate production in skeletal muscle. At the onset of exercise, oxidation of glucose and glycogen...

15 September 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
JCJun Chen
Jun Chen
EHEdward P. Hackett
Edward P. Hackett
Zoltan KovacsZoltan Kovacs
Zoltan Kovacs
CMCraig R. Malloy
Craig R. Malloy
JPJae Mo Park
Jae Mo Park

10 July 2023 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
EHEdward P. Hackett
Edward P. Hackett
JCJun Chen
Jun Chen
LILaura Ingle
Laura Ingle
SNSarah Al Nemri
Sarah Al Nemri
SBSurendra Barshikar
Surendra Barshikar
JPJae Mo Park
Jae Mo Park
Purpose: [13C]Bicarbonate formation from hyperpolarized [1‐13C]pyruvate via pyruvate dehydrogenase, a key regulatory enzyme, represents the cerebral oxidation of pyruvate and the integrity of mitochondrial function. The present study is to characterize the chronology of cerebral mitochondrial metabolism during secondary injury associated with acute traumatic brain injury (TBI) by longitudinally monitoring [13C]bicarbonate production from hyperpolarized [1‐13C]pyruvate in rodents.Methods: Male Wistar rats were randomly assigned to undergo a controlled‐cortical impact (CCI, n = 31) or sham surgery (n = 22). Seventeen of the CCI and 9 of the sham rats longitudinally underwent a 1H/13C‐integrated MR protocol that includes a bolus injection of hyperpolarized [1‐13C]pyruvate at 0 (2 h), 1, 2, 5, and 10 days post‐surgery. Separate CCI and sham rats were used for histological validation and enzyme assays.Results: In addition to elevated lactate, we observed significantly reduced bicarbonate production in the injured site. Unlike the immediate appearance of hyperintensity on T2‐weighted MRI, the contrast of bicarbonate signals between the injured region and the contralateral brain peaked at 24 h post‐injury, then fully recovered to the normal level at day 10. A subset of TBI rats demonstrated markedly increased bicarbonate in normal‐appearing contralateral brain regions post‐injury.Conclusion: This study demonstrates that aberrant mitochondrial metabolism occurring in acute TBI can be monitored by detecting [13C]bicarbonate production from hyperpolarized [1‐13C]pyruvate, suggesting that [13C]bicarbonate is a sensitive in‐vivo biomarker of the secondary injury processes.

26 February 2026 in Cardiovascular Research
Verified
Journal Article
Open access
JCJun Chen
Jun Chen
ZEZohreh Erfani
Zohreh Erfani
AEAbdallah Elnwasany
Abdallah Elnwasany
SNSarah Al Nemri
Sarah Al Nemri
JPJoseph Park
Joseph Park
JPJae Mo Park
Jae Mo Park
Aims: A ketogenic diet (KD) can suppress cardiac carbohydrate utilization, which may adversely impact heart function. However, the reversibility of KD-induced metabolic changes is poorly understood. This study aims to characterize myocardial pyruvate dehydrogenase (PDH) flux during the transition from a prolonged KD to a normal chow diet (ND). Methods and results: Cardiac metabolism was longitudinally assessed in rats using hyperpolarized [1-13C]pyruvate at baseline, during a KD (2 and 5 weeks), and a subsequent ND (1, 2, 5, and 8 days) after the 5-week KD. Hyperpolarized 13C products were compared between the KD group and age-matched ND controls. In parallel, nuclear magnetic resonance isotopomer analysis of cardiac tissue with an injection of [3-13C]pyruvate and [1,2-13C2]acetate was performed along with ex vivo enzymatic analysis of PDH activity. Myocardial [13C]bicarbonate production relative to total 13C products decreased from 8.56 ± 2.29% at baseline to 0.46 ± 0.27% after 5 weeks of KD. Reverting to ND gradually restored PDH flux (8.40 ± 1.47% by Day 8) to control levels (8.69 ± 2.10%). Ex vivo NMR analysis of glutamate C4 showed reduced pyruvate contribution to acetyl-CoA during KD (4.1 ± 2.5%), which recovered upon reverting to ND (22.7 ± 1.82% vs. control: 27.6 ± 9.5%). Although PDK4 expression normalized, PDH activity remained partially impaired in the reverted group (36.80 ± 6.07 mmol NADH/min/mg) compared to controls (90.97 ± 5.40; P = 0.00007). Conclusion: KD-induced suppression of myocardial PDH flux is reversible, but its recovery requires significant time, with prolonged metabolic inflexibility persisting after transitioning to an ND. These findings highlight the value of in vivo assessment of cardiac PDH activity, complemented by conventional enzymatic analyses, to identify persistent metabolic inflexibility following ketogenic interventions.

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
JSJayesh Sharma
Jayesh Sharma
EZElizabeth Zhang
Elizabeth Zhang
XWXuliang Wang
Xuliang Wang
JMJunjie Ma
Junjie Ma
JCJun Chen
Jun Chen
PAPrasanna Alluri
Prasanna Alluri
Background: Radiation-Induced Heart Disease (RIHD) is a major source of morbidity and mortality in patients receiving thoracic radiation, which is a common treatment for malignancies like lung cancer. There is currently no standardized program for follow-up of RIHD in cancer survivors. Therefore, there is an acute need for developing detection of RIHD at a stage that offers potential for early intervention and reversibility. The gold standard for detection of global cardiac dysfunction is echocardiography. However, this current paradigm detects cardiac changes in metrics such as Left Ventricular Ejection Fraction (LVEF), which are relatively late manifestations in the pathology of cardiotoxicity, decreasing the possibility of reversing such damage. We sought to assess radiation-induced changes significantly earlier than the current standard of care by measuring the efficiency of the tricarboxylic acid cycle in cardiac mitochondria; we hypothesized that radiation leads to impaired mitochondrial function, causing increased conversion of pyruvate to lactate in the cytosol and decreased conversion in the mitochondria. In order to non-invasively measure this impairment, we utilized Magnetic Resonance Spectroscopy (MRS) to track the fate of hyperpolarized (HP) C-13 pyruvate. Methods: Sprague-Dawley rats underwent baseline and post treatment echocardiography and HP C-13 pyruvate MRS at multiple timepoints. Half of the animals underwent image-guided cardiac radiation with cone-beam CT, to a total dose of 40 Gy in 5 fractions, a paradigm similar to a common dose given to lung cancer patients. Results: In the cardiac radiation group, C-13 pyruvate MRS demonstrated a statistically significant decrease in cardiac function (determined by bicarbonate-to-lactate ratio in myocardial mitochondria) compared to pre-radiation baseline (p=0.02, one-tailed paired t-test) as early as 1 week post treatment. No significant decrease in this ratio was observed in the non-irradiated, age matched controls (p=0.95). Comparatively, no significant changes in LVEF or global longitudinal strain were observed in either the cardiac irradiation or control group of rats until 2 months post treatment. Conclusion: Radiation-induced myocardial mitochondrial dysfunction is an early event that can be characterized and detected in vivo by hyperpolarized C-13 pyruvate MRS within 1 week after radiation prior to onset of echocardiographic changes. For the first time, we have demonstrated feasibility of employing HP C-13 pyruvate MRS for detecting radiation-induced myocardial mitochondrial metabolic changes in a pre-clinical rat model. This technology has the potential to serve as a platform for building radiation-focused cardio-oncology programs for early detection and mitigation of radiation-induced cardiac injury in hundreds of thousands of patients receiving thoracic radiation annually. Citation Format: Jayesh Sharma, Elizabeth Zhang, Xuliang Wang, Junjie Ma, Jun Chen, Gabriele Schiattarella, Joseph Hill, Jaemo Park, Craig Malloy, Vlad Zaha, Prasanna Alluri. Early in vivo detection of radiation-induced cardiotoxicity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 3659.